The Globe and Mail reports in its Friday, May 26, edition that Scotia Capital analyst Justin Strong is keeping his "sector perform" call on Anaergia intact. The Globe's David Leeder writes in the Eye On Equities column that Mr. Strong lowered his share target by $2.75 to $2. Analysts on average target the shares at $2.81. Mr. Strong says in a note: "Anaergia's subsidiary that owns 51 per cent of the company's flagship Rialto Bioenergy Facility (RBF) project has voluntarily begun restructuring proceedings. The project has been plagued by delays in ramping to full commercial operation due to delayed implementation of laws requiring organic waste diversion from landfills by the city of Los Angeles. Management remains constructive on the project. Anaergia estimates that with appropriate feedstock for the RBF facility, made feasible by debt service and other payment relief offered under a Chapter 11 reorganization to allow ramp up, the asset will preserve long-term value. While the project's long-term prospects for Anaergia remain strong and 2023 guidance is unchanged we have taken the opportunity to further risk the multiple by which we value the company's Build-Own-Operate segment."